ADDEX-ORTHO-McNEIL TIE-UP TO DEVELOP TREATMENTS FOR ANXIETY, DEPRESSION & AD

Addex Pharmaceuticals has entered an exclusive worldwide research collaboration and license agreement with Ortho-McNeil Pharmaceutical, a Johnson & Johnson company, to discover, develop and commercialize novel compounds modulating allosterically G-Protein Coupled Receptors for the treatment of anxiety, depression, schizophrenia and Alzheimer's disease.

PharmaBiz (http://www.pharmabiz.com/article/detnews.asp?articleid=25738§ionid=)